Skip to content
Catalyst

PapersPMID:37169515

L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.

Psychiatry and clinical neurosciences2023The record ↗

  1. Finding, very limited evidencelowersYale-Brown Obsessive Compulsive Scale (Y-BOCS) total score

What moved

1 findingHow to read these marks →
  • “Also, total Y-BOCS scores were lower in L-theanine compared to placebo group at week 5 (P = 0.039, Cohen's d = 0.60) and 10 (P = 0.008, Cohen's d = 0.80).”
    Study
    RCT
    Duration
    2 months
    Dose studied
    L-theanine 100 mg twice daily, oral, added to fluvoxamine
    Population
    Adults 18-60 with DSM-5 OCD and baseline Y-BOCS above 21; fluvoxamine given to both arms as background (100 mg daily, 200 mg daily after week 5); 10-week parallel-group trial; primary outcome was Y-BOCS total decrease from baseline; result recorded is the week-10 contrast

Study record

Design
randomised controlled trial
Species
human
Population
Patients aged 18 to 60 years with moderate-to-severe OCD (DSM-5), Y-BOCS score above 21
Participants
50
Comparator
placebo
Duration
70 days
Endpoints measured
7
Declined
this platform holds no node for the endpoint